VIVO - メリディアン・バイオサイエンス (Meridian Bioscience Inc.)

VIVOのニュース

   Vivo Y51A ,   2021/06/28 09:01:09 Maharashtra Times
Vivo Y51A , . Vivo India - , .
   Vivo Y51A 6GB ,   2021/06/28 08:46:58 NBT Hindi News
, 11, 5000 Vivo Y51A
   50 iPhone 11, Mi 10, OnePlus 9 5   2021/06/28 01:46:53 NBT Hindi News
50 Apple iPhone 11, Samsung Galaxy S20 FE 5G, OnePlus 9, Vivo X60 Pro Xiaomi Mi 10 5 , ,
   Vivo X60T Pro+ 50 MP 55W , X60 Pro+ ?  2021/06/28 00:43:43 NBT Hindi News
Vivo Vivo S60 Series Vivo X60T Pro+ , Vivo X60 Pro+
   5   2021/06/27 19:05:57 218TV
5 Vivo X60t Pro Plus. Snapdragon 888 Adreno 660 Android 11 Origin OS 1.0. AMOLED 6.56 FHD Plus 2376*1080 The post 5 appeared first on 218 .
   VIVO Cannabis™ Announces Closing of $8 Million Overnight Marketed Public Offering Including Full Exercise of Over-Allotment Option  2021/02/26 14:59:00 Cision (Canada)
/CNW/ - VIVO Cannabis Inc. (TSX: VIVO) ("VIVO" or the "Company") announced today the closing of its previously announced overnight marketed public offering…
   GI Stool Testing Market 2021 Leading Countries, Challenges, Five Forces Analysis, Trends, Drivers, Forecast to 2023 | BioMrieux Inc. Meridian Bioscience Inc. DiaSorin S.p.A. Beckman Coulter Inc. Alere Inc.  2021/02/24 14:07:51 OpenPR
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘GI Stool Testing Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The GI Stool Testing Market is expected to witness growth in upcoming years due to factors such as increase in
   Cannabis Stock Gainers And Losers From February 11, 2021  2021/02/11 22:24:49 Benzinga
GAINERS: MGC Pharmaceuticals (PINK: MGCLF ) shares closed up 32.23% at $0.05 Pharmadrug (PINK: LMLLF ) shares closed up 5% $0.10 BioHarvest Sciences (PINK: CNVCF ) shares closed up 21.35% at$0.54 Abattis Bioceuticals (PINK: ATTBF ) shares closed up 17.65% at $0.04 Target Group (OTCQB: CBDY ) shares closed up 10.32% at $0.07 Meridian Bioscience (OTCQX: VIVO ) shares closed up 8.89% at $29.89 22nd Century Group, Inc. Common Stock (NYSEMKT: XXII ) shares closed up 7.16% at $3.74 Zelira Therapeutics (OTCQB: ZLDAF ) shares closed up 6.31% at $0.08 Teradyne (OTC: TER ) shares closed up 4.92% at $135.04 AusCann Group Holdings (PINK: ACNNF ) shares closed up 3.23% at $0.16 World Acceptance ( WRLD ) shares closed up 2.35% at $128.88 Full story available on Benzinga.com
   Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day  2021/02/11 14:01:02 Yahoo Finance UK
Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day
   John P. Kenny Sells 68,288 Shares of Meridian Bioscience, Inc. (NASDAQ:VIVO) Stock  2021/02/10 20:30:43 Watchlist News
Meridian Bioscience, Inc. (NASDAQ:VIVO) CEO John P. Kenny sold 68,288 shares of the stock in a transaction dated Monday, February 8th. The stock was sold at an average price of $29.86, for a total value of $2,039,079.68. Following the completion of the sale, the chief executive officer now directly owns 304,330 shares of the company’s […]
   Meridian Bioscience, Inc. to Host Earnings Call  2021/02/05 13:15:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / February 5, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on February 5, 2021 at 10:00 AM Eastern Time.
   H.C. Wainwright Stick to Their Buy Rating for Meridian Bioscience Inc. By Investing.com  2021/02/04 11:29:06 Investing.com
H.C. Wainwright Stick to Their Buy Rating for Meridian Bioscience Inc.
   Meridian’s Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays  2021/02/02 13:00:00 Yahoo Finance
CINCINNATI, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has developed a series of innovative and high performing master mixes designed for manufacturing room-temperature stable molecular diagnostic assays that do not require lyophilization. The conventional approach to manufacture room-temperature stable molecular assay is lyophilization, which is expensive, time consuming, and requires expertise and sophisticated equipment. Meridian’s new air-dryable master mixes for DNA/RNA detection replace the need for lyophilization with a fast, simple and inexpensive oven-drying procedure. A unique advantage of Meridian’s air-dryable master mixes is their ability to effectively preserve the performance and integrity of the enzymes throughout the oven-drying process. Meridian’s air-dryable master mixes also exhibit higher tolerance to PCR inhibitors, when compared to lyophilized or liquid-formats, regardless of the sample type (e.g., urine, stool, blood, saliva, waste water, plant, etc.) In addition, air-dryable master mixes are ideal for molecular assays that require multiplexing or are price sensitive.
   FXNEWS24 |Meridian Bioscience (VIVO) Gains As Market Dips: What You Should Know | UK Forex Reviews  2021/01/30 04:01:23 FXNews24
Meridian Bioscience (VIVO) Gains As Market Dips: What You Should Know | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News
   Global Preliminary Screening Tests Market 2021:Thriving Worldwide||Players-Bio-rad Laboratories, Inc., Cepheid., Hologic Inc., Meridian Bioscience, Inc., OraSure Technologies  2021/01/25 13:13:59 OpenPR
The demand for preliminary screening tests is projected to achieve market share over the 2020 to 2027 forecast period. Data Bridge Market Research analyses the demand in the projected timeframe to expand at a CAGR of 7.11 percent. Increasing awareness

calendar